Showing 281 - 300 results of 101,050 for search '(( 2 step decrease ) OR ( 5 ((((mm decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.41s Refine Results
  1. 281

    Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype. by Stephanie L. Easter (662168)

    Published 2014
    “…Values are means +/− standard error (n = 6 MMTV-Wnt1, 3 fields per tumor; n = 5 MMTV-Wnt1;MMTV-Wnt5a, 3 fields per tumor). MMTV-Wnt1;MMTV-Wnt5a tumors demonstrated a significant decrease in K6-expressing cells as measured by T-test (* = p<0.05).…”
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288

    Nucleophilicity of Oximes Based upon Addition to a Nitrilium <i>closo</i>-Decaborate Cluster by Dmitrii S. Bolotin (1953220)

    Published 2016
    “…The results of DFT calculations indicate that the mechanism for these reactions is stepwise and is realized through the formation of the orientation complex of the nitrone form, R<sup>2</sup>R<sup>3</sup>CN<sup>+</sup>­(H)­O<sup>–</sup>, of oximes with [B<sub>10</sub>H<sub>9</sub>­NCEt]<sup>−</sup>, giving further an acyclic intermediate (the rate-determining step), followed by proton migration, leading to the addition product. …”
  9. 289

    Nucleophilicity of Oximes Based upon Addition to a Nitrilium <i>closo</i>-Decaborate Cluster by Dmitrii S. Bolotin (1953220)

    Published 2016
    “…The results of DFT calculations indicate that the mechanism for these reactions is stepwise and is realized through the formation of the orientation complex of the nitrone form, R<sup>2</sup>R<sup>3</sup>CN<sup>+</sup>­(H)­O<sup>–</sup>, of oximes with [B<sub>10</sub>H<sub>9</sub>­NCEt]<sup>−</sup>, giving further an acyclic intermediate (the rate-determining step), followed by proton migration, leading to the addition product. …”
  10. 290

    Fig 5 - by David Mathar (9707947)

    Published 2022
    Subjects:
  11. 291

    S5 Fig - by David Mathar (9707947)

    Published 2022
    Subjects:
  12. 292

    OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

    Published 2019
    “…After 4 weeks, when the tumor size was approximately 100 mm<sup>3</sup> (T<sub>0</sub>) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”
  13. 293
  14. 294

    Fig 5 - by Matthew C. Kochem (18476069)

    Published 2024
    Subjects:
  15. 295
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300